BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9712019)

  • 1. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
    Collinge M; Pardi R; Bender JR
    J Immunol; 1998 Aug; 161(4):1589-93. PubMed ID: 9712019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms.
    Watson CA; Petzelbauer P; Zhou J; Pardi R; Bender JR
    J Immunol; 1995 Apr; 154(7):3222-33. PubMed ID: 7897208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate.
    Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE
    J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
    Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
    J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line.
    Vedrenne J; Assier E; Pereno R; Bouzinba-Segard H; Azzarone B; Jasmin C; Charron D; Krief P
    Oncogene; 1997 Mar; 14(12):1453-61. PubMed ID: 9136989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
    Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
    J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
    J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: phorbol ester induction of IFN-gamma receptors leads to enhanced DR alpha gene expression.
    Sakamoto S; Nie J; Taniguchi T
    J Immunol; 1999 Apr; 162(8):4381-4. PubMed ID: 10201972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.
    Lu Y; Ussery GD; Muncaster MM; Gallie BL; Blanck G
    Oncogene; 1994 Apr; 9(4):1015-9. PubMed ID: 8134104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y; Zhou ZH; Ransohoff RM
    J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
    Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T
    J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
    Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
    J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.